JeanMichel Grandmougin - Eurobio Scientific CEO Board
| ALERS Stock | 25.75 0.05 0.19% |
Insider
JeanMichel Grandmougin is CEO Board of Eurobio Scientific SA
| Age | 62 |
| Phone | 33 1 69 79 64 80 |
| Web | https://www.eurobio-scientific.com |
Eurobio Scientific Management Efficiency
The company has return on total asset (ROA) of 0.2293 % which means that it generated a profit of $0.2293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4506 %, meaning that it generated $0.4506 on every $100 dollars invested by stockholders. Eurobio Scientific's management efficiency ratios could be used to measure how well Eurobio Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Benoit Bonduelle | Bonduelle SCA | N/A | |
| Yan MD | Ipsen SA | 56 | |
| Paul Sekhri | Ipsen SA | 61 | |
| Ekaterina Eliseeva | Bonduelle SCA | N/A | |
| Valrie LorentzPoinsot | Boiron SA | 54 | |
| Guillaume Debrosse | Bonduelle SCA | N/A | |
| Manuela Rodrguez | Virbac SA | N/A | |
| Steven Hildemann | Ipsen SA | N/A | |
| JeanChristophe Bayssat | Boiron SA | 60 | |
| Gianfranco DAmico | Bonduelle SCA | N/A | |
| Michel Torris | Bonduelle SCA | N/A | |
| Celine Barral | Bonduelle SCA | N/A | |
| Bertrand Havrileck | Virbac SA | N/A | |
| Eric Lambert | Boiron SA | N/A | |
| Stephan Gagne | Ipsen SA | N/A | |
| Sandrine Brunel | Virbac SA | N/A | |
| Nathalie Pollet | Virbac SA | N/A | |
| Daniel Vielfaure | Bonduelle SCA | N/A | |
| Marine Henin | Bonduelle SCA | N/A | |
| Gwenan White | Ipsen SA | N/A | |
| Christine Place | Boiron SA | N/A | |
Management Performance
| Return On Equity | 0.45 | |||
| Return On Asset | 0.23 |
Eurobio Scientific Leadership Team
Elected by the shareholders, the Eurobio Scientific's board of directors comprises two types of representatives: Eurobio Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eurobio. The board's role is to monitor Eurobio Scientific's management team and ensure that shareholders' interests are well served. Eurobio Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eurobio Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JeanMichel Grandmougin, CEO Board | ||
| Denis Fortier, Director CEO | ||
| Jacques Martin, VP Marketing | ||
| Herve MBA, Director, CEO | ||
| Thomas Iff, Chief Officer |
Eurobio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eurobio Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.23 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 124.11 M | |||
| Shares Outstanding | 11.34 M | |||
| Shares Owned By Insiders | 30.93 % | |||
| Shares Owned By Institutions | 6.77 % | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 1.30 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eurobio Stock Analysis
When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.